Clinical trialNCT04780685UnknownPhase 2Interventional

A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19

SponsorStemedica Cell Technologies, Inc.Enrollment40Covid19

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a Phase II multi-center, double-blind, placebo-controlled, randomized study in Patients with moderate to severe lung injury due to COVID-19 or other potential viral and bacterial pathogens.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Lev Verkh, PhD/MS
Stemedica Cell Technologies, Inc.
Study Director
clinicaltrials.gov ↗
Santosh Kesari, MD
Providence Saint John's Health Center - Saint John's Cancer
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Providence Medical Foundation
Fullerton, California, United States
David Park, MD
Recruiting
Providence Saint John'S Health Center - Saint John'S Cancer Institute
Santa Monica, California, United States
Santosh Kesari, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

HMSC

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 20 Mar 2021
Primary completion: 30 Sept 2022
Completion: 31 Dec 2022
Last update posted: 8 Jul 2022
Registered enrollment: 40
Registry id: NCT04780685

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.